Allan Carsten Dahl

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignees: H. Lundbeck A/s, Other. Active years: 2010-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Allan Carsten Dahl. Retrieved from https://idiyas.com/inventor/allan-carsten-dahl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 16.7

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 48(Granted Patents)

Company Filing History:

5 out of 513

H. Lundbeck A/s

patents

1 out of 834,453

Other

patents

Years Active: 2010-2013

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8569499 - Process for making trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine (2013-10-29),

2. 8501947 - Manufacture of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine (2013-08-06),

3. 8227607 - Processes for 4-((1R,35)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a salt thereof (2012-07-24),

4. 8076342 - Malonate salt of 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of same (2011-12-13),

5. 7772240 - [object Object] (2010-08-10),

6. 7767683 - Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament (2010-08-03),

Title: Innovations of Allan Carsten Dahl

Introduction

Allan Carsten Dahl is a notable inventor based in Nyrup, Denmark. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. With a total of 6 patents to his name, Dahl's work has had a considerable impact on the industry.

Latest Patents

Dahl's latest patents include a process for making trans-1-((1R,3S)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine. This patent describes a method for synthesizing this compound and its salts. Another significant patent involves the manufacture of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine, along with its pharmaceutically acceptable salts. These innovations showcase his expertise in chemical processes and pharmaceutical development.

Career Highlights

Throughout his career, Allan Carsten Dahl has worked with H. Lundbeck A/S, a prominent pharmaceutical company. His experience in this organization has allowed him to refine his skills and contribute to various innovative projects.

Collaborations

Dahl has collaborated with notable colleagues such as Benny Bang-Andersen and Henrik Svane. These partnerships have likely enhanced his research and development efforts, leading to successful innovations in his field.

Conclusion

Allan Carsten Dahl's contributions to the field of chemistry and pharmaceuticals are noteworthy. His patents reflect a commitment to innovation and advancement in drug development. His work continues to influence the industry positively.

Profile summary based on public USPTO records.